ADALIMUMAB POUR L'UTILISATION DANS LA THÉRAPIE DE L'ARTHRITE RHUMATOÏDE
- 专利权人:
- AbbVie Biotechnology Ltd
- 发明人:
- 申请号：
- EP16198524.7
- 公开号：
- EP3190124A1
- 申请日:
- 2002.06.05
- 申请国别(地区):
- EP
- 年份:
- 2017
- 代理人:
- 摘要：
- Methods of treating rheumatoid arthritis via biweekly, subcutaneous administration of 40 mg of the anti-TNF antibody adalimumab (2DE7). The antibody may be administered with or without methotrexate. .
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Compositions for the treatment of rheumatoid arthritis and methods of use thereof
- TAPENTADOL FOR TREATING PAIN FROM ARTHRITIS
- Compositions and methods for treating inflammatory arthritis
- Compositions for the treatment of rheumatoid arthritis and Methods for their use
- TREATMENT OF RHEUMATOID ARTHRITIS WITH A COMBINATION OF LAQUINIMOD AND METHOTREXATE
